Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Frontotemporal dementia and tauopathy.

Y Yoshiyama1, V M Lee, J Q Trojanowski

  • 1Center for Neurodegenerative Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania, 3400 Spruce Street, 3rd Floor Maloney, Philadelphia, PA 19104, USA.

Current Neurology and Neuroscience Reports
|March 20, 2002
PubMed
Summary

Neurofibrillary lesions from hyperphosphorylated tau proteins define tauopathies. Research is advancing our understanding of these neurodegenerative disorders and exploring therapeutic interventions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: How Will Aducanumab Approval Impact AD Research?

The journal of prevention of Alzheimer's disease·2021
Same author

Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.

Acta neuropathologica communications·2021
Same author

Pathological drivers of neurodegeneration in suspected non-Alzheimer's disease pathophysiology.

Alzheimer's research & therapy·2021
Same author

Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.

Neuropathology and applied neurobiology·2020
Same author

Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis.

Acta neuropathologica communications·2018
Same author

Connexin-43 and aquaporin-4 are markers of ageing-related tau astrogliopathy (ARTAG)-related astroglial response.

Neuropathology and applied neurobiology·2017

Area of Science:

  • Neuroscience
  • Neuropathology
  • Genetics

Background:

  • Tauopathies are neurodegenerative disorders characterized by neurofibrillary lesions of hyperphosphorylated tau proteins.
  • Mutations in the tau gene (FTDP-17) confirm tau's role in neurodegenerative disease pathogenesis.
  • Sporadic frontotemporal dementia (FTD) is also a tauopathy linked to reduced tau protein expression.

Purpose of the Study:

  • To review current understanding of human neurodegenerative tauopathies.
  • To explore prospects for translating recent insights into therapeutic interventions.

Main Methods:

  • Review of existing literature on tauopathies and related genetic mutations.
  • Analysis of findings from transgenic mouse models expressing human tau variants.

Related Experiment Videos

  • Examination of neuropathologic diagnostic criteria for FTD and tauopathies.

    • Main Results:

    • Tau gene mutations and altered tau expression are key factors in FTD and other tauopathies.
    • Transgenic mouse models replicate key features of human tauopathies, including tau pathologies and brain degeneration.
    • Understanding of disease mechanisms is evolving, impacting classification and diagnosis.

    Conclusions:

    • Tau protein dysfunction is central to the pathogenesis of a significant group of neurodegenerative disorders.
    • Further research into disease mechanisms is crucial for developing effective therapeutic strategies for tauopathies.